Invention Grant
- Patent Title: Quinazoline-based T cell proliferation inhibitors
- Patent Title (中): 基于喹唑啉的T细胞增殖抑制剂
-
Application No.: US13575573Application Date: 2011-01-27
-
Publication No.: US08759363B2Publication Date: 2014-06-24
- Inventor: Alexander Levitzki , Idit Sagiv
- Applicant: Alexander Levitzki , Idit Sagiv
- Applicant Address: IL Jerusalem
- Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
- Current Assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
- Current Assignee Address: IL Jerusalem
- Agency: Browdy and Neimark PLLC
- International Application: PCT/IL2011/000093 WO 20110127
- International Announcement: WO2011/092695 WO 20110804
- Main IPC: A01N43/90
- IPC: A01N43/90 ; A61K31/522
Abstract:
Quinazoline derivatives are provided that specifically inhibit proliferation of T cells without affecting the level of IL-2 secreted from said T cells. These compounds as well as pharmaceutical composition comprising them are useful for the treatment of indications mediated by T cell proliferation.
Public/Granted literature
- US20130109706A1 QUINAZOLINE-BASED T CELL PROLIFERATION INHIBITORS Public/Granted day:2013-05-02
Information query
IPC分类:
